The Magnum Ice Cream Company N.V. Ordinary Shares vs Vir Biotechnology Inc. Common Stock — how do they compare? The Magnum Ice Cream Company N.V. Ordinary Shares trades at $17.92 (market cap $10.72B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: The Magnum Ice Cream Company N.V. Ordinary Shares is far larger — about 6× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, The Magnum Ice Cream Company N.V. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold The Magnum Ice Cream Company N.V. Ordinary Shares for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| MICC | VIR | |
|---|---|---|
Market Cap | $10.72B | $1.80B |
Volume | 1,309,650 | 1,782,836 |
Sector | Consumer Staples | Health |
52-Week High | $20.42 | $11.78 |
52-Week Low | $13.06 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $14.14B | $1.36B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
The Magnum Ice Cream Company N.V. manufactures and sells ice cream and frozen desserts through brands including Magnum, Ben & Jerry's, Wall's, and Cornetto, distributing across roughly 80 countries.
Read more on MICC →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →